Viking Therapeutics logo
Viking Therapeutics VKTX
$ 64.61 2.34%

Quarterly report 2024-Q3
added 10-23-2024

report update icon

Viking Therapeutics ROCE Ratio 2011-2024 | VKTX

Annual ROCE Ratio Viking Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-28.86 -48.0 -27.58 -0.02 -11.78 -8.79 -141.63 -171.82 -89.11 - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-0.02 -171.82 -58.62

Quarterly ROCE Ratio Viking Therapeutics

2024-Q3 2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-22.47 -24.59 -28.7 -39.31 -42.54 -47.08 -30.12 -36.41 -32.09 -28.33 -19.19 -23.22 -20.96 -18.39 -12.85 -15.53 -14.18 -13.29 -8.58 -11.07 -10.87 -9.74 -6.42 -41.27 -73.64 -108.3 -99.93 -140.44 -146.09 -153.5 -125.44 -157.3 -148.65 -123.76 -54.79 -48.89 -11.14 120.09 118.69 118.69 112.79 1.08 - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
120.09 -157.3 -35.18